characterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1121-1128

  Campos, Cristine G ^a   Borst, Luke ^b   Cotter, Peggy A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCAA PROTEIN; BCAB PROTEIN; COMPLEMENTARY DNA; OUTER MEMBRANE PROTEIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SUBTILISIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HEPATITIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MELIOIDOSIS; MOUSE; MUTANT; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; RNA ISOLATION; SPLEEN; WILD TYPE;

ANIMALS; BACTERIAL ADHESION; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL SECRETION SYSTEMS; BURKHOLDERIA PSEUDOMALLEI; CELL LINE; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; EPITHELIAL CELLS; FEMALE; HUMANS; LIVER; LUNG; MELIOIDOSIS; MICE; MICE, INBRED BALB C; PROTEIN TRANSPORT; SEQUENCE DELETION; SPLEEN; VIRULENCE FACTORS;

EID: 84875543227     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01453-12     Document Type: Article

References (43)

1. Holden MT, Titball RW, Peacock SJ, Cerdeno-Tarraga AM, Atkins T, Crossman LC, Pitt T, Churcher C, Mungall K, Bentley SD, Sebaihia M, Thomson NR, Bason N, Beacham IR, Brooks K, Brown KA, Brown NF, Challis GL, Cherevach I, Chillingworth T, Cronin A, Crossett B, Davis P, DeShazer D, Feltwell T, Fraser A, Hance Z, Hauser H, Holroyd S, Jagels K, Keith KE, Maddison M, Moule S, Price C, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Simmonds M, Songsivilai S, Stevens K, Tumapa S, Vesaratchavest M, Whitehead S, Yeats C, Barrell BG, Oyston PC, Parkhill J. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. U. S. A. 101:14240-14245.
2. Sprague LD, Neubauer H. 2004. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J. Vet. Med. B Infect. Dis. Vet. Public Health 51:305-320.
3. Whitmore A, Krisnaswami CS. 1912. An account of the discovery of a hitherto undescribed infective disease occurring among the population of Ragoon. Ind. Med. Gaz. 262-267.
4. Inglis TJ, Sagripanti JL. 2006. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. Appl. Environ. Microbiol. 72:6865-6875.
5. Wiersinga WJ, Currie BJ, Peacock SJ. 2012. Melioidosis. N. Engl. J. Med. 367:1035-1044.
6. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
7. Dorman SE, Gill VJ, Gallin JI, Holland SM. 1998. Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin. Infect. Dis. 26:889-894.
8. Rolim DB, Vilar DC, Sousa AQ, Miralles IS, de Oliveira DC, Harnett G, O'Reilly L, Howard K, Sampson I, Inglis TJ. 2005. Melioidosis, northeastern Brazil. Emerg. Infect. Dis. 11:1458-1460.
9. Yabuuchi E, Kosako Y, Arakawa M, Hotta H, Yano I. 1992. Identification of Oklahoma isolate as a strain of Pseudomonas pseudomallei. Microbiol. Immunol. 36:1239-1249.
10. Valvano MA, Keith KE, Cardona ST. 2005. Survival and persistence of opportunistic Burkholderia species in host cells. Curr. Opin. Microbiol. 8:99-105.
11. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D. 2004. Type V protein secretion pathway: the autotransporter story. Microbiol. Mol. Biol. Rev. 68:692-744.
12. Henderson IR, Nataro JP. 2001. Virulence functions of autotransporter proteins. Infect. Immun. 69:1231-1243.
13. Cotter SE, Surana NK, St Geme JW, III. 2005. Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol. 13:199-205.
14. Nishimura K, Tajima N, Yoon YH, Park SY, Tame JR. 2010. Autotransporter passenger proteins: virulence factors with common structural themes. J. Mol. Med. (Berl) 88:451-458.
15. Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD. 2009. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol. Rev. 33: 1079-1099.
16. French CT, Toesca IJ, Wu TH, Teslaa T, Beaty SM, Wong W, Liu M, Schroder I, Chiou PY, Teitell MA, Miller JF. 2011. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc. Natl. Acad. Sci. U. S. A. 108:12095-12100.
17. Stevens MP, Haque A, Atkins T, Hill J, Wood MW, Easton A, Nelson M, Underwood-Fowler C, Titball RW, Bancroft GJ, Galyov EE. 2004. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150:2669-2676.
18. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, Scorpio A, Milne TS, Dean RE, Fritz DL, Peacock SJ, Prior JL, Atkins TP, Deshazer D. 2011. The cluster 1 type VI secretion system is a majorvirulence determinant in Burkholderia pseudomallei. Infect. Immun. 79: 1512-1525.
19. Pantaloni D, Le Clainche C, Carlier MF. 2001. Mechanism of actinbased motility. Science 292:1502-1506.
20. Stevens MP, Stevens JM, Jeng RL, Taylor LA, Wood MW, Hawes P, Monaghan P, Welch MD, Galyov EE. 2005. Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Mol. Microbiol. 56:40-53.
21. López CM, Rholl DA, Trunck LA, Schweizer HP. 2009. Versatile dualtechnology system for markerless allele replacement in Burkholderia pseudomallei. Appl. Environ. Microbiol. 75:6496-6503.
22. Mima T, Schweizer HP. 2010. The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob. Agents Chemother. 54: 3113-3120.
23. Choi KH, Mima T, Casart Y, Rholl D, Kumar A, Beacham IR, Schweizer HP. 2008. Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. Appl. Environ. Microbiol. 74:1064-1075.
24. Goodyear A, Kellihan L, Bielefeldt-Ohmann H, Troyer R, Propst K, Dow S. 2009. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy. Infect. Immun. 77:1579-1588.
25. Choi KH, DeShazer D, Schweizer HP. 2006. mini-Tn7 insertion in bacteria with multiple glmS-linked attTn7 sites: example Burkholderia mallei ATCC 23344. Nat. Protoc. 1:162-169.
26. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
28. Letunic I, Doerks T, Bork P. 2012. SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res. 40(Database issue): D302-D305.
29. Kespichayawattana W, Intachote P, Utaisincharoen P, Sirisinha S. 2004. Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells. Microb. Pathog. 36:287-292.
30. Krem MM, Di Cera E. 2001. Molecular markers of serine protease evolution. EMBO J. 20:3036-3045.
31. Siezen RJ, Leunissen JA. 1997. Subtilases: the superfamily of subtilisinlike serine proteases. Protein Sci. 6:501-523.
32. Tripathi LP, Sowdhamini R. 2008. Genome-wide survey of prokaryotic serine proteases: analysis of distribution and domain architectures of five serine protease families in prokaryotes. BMC Genomics 9:549. doi:10.1186/1471-2164-9-549.
33. Ohnishi Y, Horinouchi S. 1996. Extracellular production of a Serratia marcescens serine protease in Escherichia coli. Biosci. Biotechnol. Biochem. 60:1551-1558.
34. Ali T, Oldfield NJ, Wooldridge KG, Turner DP, Ala'Aldeen DA. 2008. Functional characterization of AasP, a maturation protease autotransporter protein of Actinobacillus pleuropneumoniae. Infect. Immun. 76: 5608-5614.
35. Handley SA, Newberry RD, Miller VL. 2005. Yersinia enterocolitica invasin-dependent and invasin-independent mechanisms of systemic dissemination. Infect. Immun. 73:8453-8455.
36. Marra A, Isberg RR. 1997. Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium. Infect. Immun. 65:3412-3421.
37. Goodyear A, Bielefeldt-Ohmann H, Schweizer H, Dow S. 2012. Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One 7:e37324. doi:10.1371/journal.pone.0037324.
38. Dance DA. 2000. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop. 74:159-168.
39. Gorres KL, Raines RT. 2010. Prolyl 4-hydroxylase. Crit. Rev. Biochem. Mol. Biol. 45:106-124.
40. Holmgren SK, Bretscher LE, Taylor KM, Raines RT. 1999. A hyperstable collagen mimic. Chem. Biol. 6:63-70.
41. Dunn DM, Franzblau C. 1982. Effects of ascorbate on insoluble elastin accumulation and cross-link formation in rabbit pulmonary artery smooth muscle cultures. Biochemistry 21:4195-4202.
42. Culpepper MA, Scott EE, Limburg J. 2010. Crystal structure of prolyl 4-hydroxylase from Bacillus anthracis. Biochemistry 49:124-133.
43. Leakey AK, Ulett GC, Hirst RG. 1998. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb. Pathog. 24:269-275.